{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:09:46Z","timestamp":1793318986700,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-025-05491-8","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:42:44Z","timestamp":1759405364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rethinking post-sepsis syndrome: linking cellular dysfunction to the clinical picture"],"prefix":"10.1186","volume":"29","author":[{"given":"Gabriel-Petre","family":"Gorecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Bodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius-Bogdan","family":"Novac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Gabriel","family":"Costea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel-Ovidiu","family":"Costea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea-Cristina","family":"Costea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u0103t\u0103lin-Nicolae","family":"Grasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana-Rodica","family":"Tomescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"5491_CR1","doi-asserted-by":"publisher","unstructured":"Wiersinga WJ, van der Poll T. Immunopathophysiology of human sepsis. EBioMedicine. 2022;86. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104363.","DOI":"10.1016\/j.ebiom.2022.104363"},{"key":"5491_CR2","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.2147\/IDR.S390947","volume":"16","author":"EC van der Slikke","year":"2023","unstructured":"van der Slikke EC, Beumeler LFE, Bouma HR, Holmqvist M, Linder A, Mankowski RT. Understanding Post-Sepsis syndrome: how can clinicians help?? Infect Drug Resist. 2023;16:6493\u2013511. https:\/\/doi.org\/10.2147\/IDR.S390947.","journal-title":"Infect Drug Resist"},{"key":"5491_CR3","doi-asserted-by":"publisher","unstructured":"Zou S, Jie H, Han X, Wang J. The role of neutrophil extracellular traps in sepsis and sepsis-related acute lung injury. Int Immunopharmacol. 2023;124. https:\/\/doi.org\/10.1016\/j.intimp.2023.110436.","DOI":"10.1016\/j.intimp.2023.110436"},{"key":"5491_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13054-025-05283-0","volume":"29","author":"A Retter","year":"2025","unstructured":"Retter A, Singer M, Annane D. The NET effect: neutrophil extracellular traps\u2014a potential key component of the dysregulated host immune response in sepsis. Crit Care 2025. 2025;29:1. https:\/\/doi.org\/10.1186\/S13054-025-05283-0.","journal-title":"Crit Care 2025"},{"key":"5491_CR5","doi-asserted-by":"publisher","unstructured":"Meng S, Xu B, Yang W, Zhao M. Microparticle-associated tissue factor activity correlates with the inflammatory response in septic disseminated intravascular coagulation patients. PeerJ 2024;12. https:\/\/doi.org\/10.7717\/peerj.16636","DOI":"10.7717\/peerj.16636"},{"key":"5491_CR6","doi-asserted-by":"publisher","unstructured":"Sachetto ATA, Archibald SJ, Hisada Y, Rosell A, Havervall S, van Es N et al. Tissue factor activity of small and large extracellular vesicles in different diseases. Res Pract Thromb Haemost 2023;7. https:\/\/doi.org\/10.1016\/j.rpth.2023.100124","DOI":"10.1016\/j.rpth.2023.100124"},{"key":"5491_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5492\/WJCCM.V12.I3.139","volume":"12","author":"W Nedel","year":"2023","unstructured":"Nedel W, Deutschendorf C, Portela LVC. Sepsis-induced mitochondrial dysfunction: A narrative review. World J Crit Care Med. 2023;12:139. https:\/\/doi.org\/10.5492\/WJCCM.V12.I3.139.","journal-title":"World J Crit Care Med"},{"key":"5491_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/S00063-023-01088-7","volume":"118","author":"C Fleischmann-Struzek","year":"2023","unstructured":"Fleischmann-Struzek C, Rudd K. Challenges of assessing the burden of sepsis. Med Klin Intensivmed Notfmed. 2023;118:68. https:\/\/doi.org\/10.1007\/S00063-023-01088-7.","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"5491_CR9","doi-asserted-by":"publisher","first-page":"628302","DOI":"10.3389\/FMED.2021.628302","volume":"8","author":"D Jarczak","year":"2021","unstructured":"Jarczak D, Kluge S, Nierhaus A. Sepsis\u2014Pathophysiology and therapeutic concepts. Front Med (Lausanne). 2021;8:628302. https:\/\/doi.org\/10.3389\/FMED.2021.628302.","journal-title":"Front Med (Lausanne)"},{"key":"5491_CR10","doi-asserted-by":"publisher","first-page":"15638","DOI":"10.18632\/AGING.103726","volume":"12","author":"JX Liu","year":"2020","unstructured":"Liu JX, Yang C, Liu ZJ, Su HY, Zhang WH, Pan Q, et al. Protection of Procyanidin B2 on mitochondrial dynamics in sepsis associated acute kidney injury via promoting Nrf2 nuclear translocation. Aging. 2020;12:15638\u201355. https:\/\/doi.org\/10.18632\/AGING.103726.","journal-title":"Aging"},{"key":"5491_CR11","doi-asserted-by":"publisher","first-page":"102968","DOI":"10.1016\/J.REDOX.2023.102968","volume":"68","author":"FM Lira Chavez","year":"2023","unstructured":"Lira Chavez FM, Gartzke LP, van Beuningen FE, Wink SE, Henning RH, Krenning G, et al. Restoring the infected powerhouse: mitochondrial quality control in sepsis. Redox Biol. 2023;68:102968. https:\/\/doi.org\/10.1016\/J.REDOX.2023.102968.","journal-title":"Redox Biol"},{"key":"5491_CR12","doi-asserted-by":"publisher","first-page":"1429370","DOI":"10.3389\/fmed.2024.1429370","volume":"11","author":"Z Yang","year":"2024","unstructured":"Yang Z, Gao Y, Zhao L, Lv X, Du Y. Molecular mechanisms of Sepsis attacking the immune system and solid organs. Front Med (Lausanne). 2024;11:1429370. https:\/\/doi.org\/10.3389\/fmed.2024.1429370.","journal-title":"Front Med (Lausanne)"},{"key":"5491_CR13","doi-asserted-by":"publisher","unstructured":"Srdi\u0107 T, \u0110ura\u0161evi\u0107 S, Laki\u0107 I, Ru\u017ei\u010di\u0107 A, Vujovi\u0107 P, Jev\u0111ovi\u0107 T, et al. From molecular mechanisms to clinical therapy: Understanding Sepsis-Induced multiple organ dysfunction. Int J Mol Sci 2024. Page 7770 2024;25:25:7770. https:\/\/doi.org\/10.3390\/IJMS25147770.","DOI":"10.3390\/IJMS25147770"},{"key":"5491_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/S41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9:53. https:\/\/doi.org\/10.1038\/S41392-024-01757-9.","journal-title":"Signal Transduct Target Ther"},{"key":"5491_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/NRNEPH.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G. Advances in the Understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14:121\u201337. https:\/\/doi.org\/10.1038\/NRNEPH.2017.165.","journal-title":"Nat Rev Nephrol"},{"key":"5491_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395:200. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"5491_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3947\/IC.2017.49.1.10","volume":"49","author":"DW Park","year":"2017","unstructured":"Park DW, Zmijewski JW. Mitochondrial dysfunction and immune cell metabolism in Sepsis. Infect Chemother. 2017;49:10. https:\/\/doi.org\/10.3947\/IC.2017.49.1.10.","journal-title":"Infect Chemother"},{"key":"5491_CR18","doi-asserted-by":"publisher","first-page":"E1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving Sepsis campaign: international guidelines for management of Sepsis and septic shock 2021. Crit Care Med. 2021;49:E1063\u2013143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337.","journal-title":"Crit Care Med"},{"key":"5491_CR19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s15010-024-02181-5","volume":"52","author":"S Piedmont","year":"2024","unstructured":"Piedmont S, Goldhahn L, Swart E, Robra BP, Fleischmann-Struzek C, Somasundaram R, et al. Sepsis incidence, suspicion, prediction and mortality in emergency medical services: a cohort study related to the current international sepsis guideline. Infection. 2024;52:1325\u201335. https:\/\/doi.org\/10.1007\/s15010-024-02181-5.","journal-title":"Infection"},{"key":"5491_CR20","doi-asserted-by":"publisher","first-page":"117494","DOI":"10.1016\/J.BIOPHA.2024.117494","volume":"180","author":"Y Kong","year":"2024","unstructured":"Kong Y, Zhang Q, Wang S, Li R, Fu C, Wei Q. Mitochondrial metabolism regulated macrophage phenotype in myocardial infarction. Biomed Pharmacother. 2024;180:117494. https:\/\/doi.org\/10.1016\/J.BIOPHA.2024.117494.","journal-title":"Biomed Pharmacother"},{"key":"5491_CR21","doi-asserted-by":"publisher","first-page":"664896","DOI":"10.3389\/fcell.2021.664896","volume":"9","author":"CL Zhu","year":"2021","unstructured":"Zhu CL, Yao RQ, Li LX, Li P, Xie J, Wang JF, et al. Mechanism of mitophagy and its role in Sepsis induced organ dysfunction: A review. Front Cell Dev Biol. 2021;9:664896. https:\/\/doi.org\/10.3389\/fcell.2021.664896.","journal-title":"Front Cell Dev Biol"},{"key":"5491_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/S13054-020-03436-X","volume":"25","author":"JW Hwang","year":"2021","unstructured":"Hwang JW, Lee MJ, Chung TN, Lee HAR, Lee JH, Choi SY, et al. The immune modulatory effects of mitochondrial transplantation on cecal slurry model in rat. Crit Care. 2021;25:20. https:\/\/doi.org\/10.1186\/S13054-020-03436-X.","journal-title":"Crit Care"},{"key":"5491_CR23","doi-asserted-by":"publisher","unstructured":"Zhang T, Yu-Jing L, Ma T. Role of regulation of PD-1 and PD-L1 expression in sepsis. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1029438.","DOI":"10.3389\/fimmu.2023.1029438"},{"key":"5491_CR24","doi-asserted-by":"publisher","unstructured":"Owen AM, Patel SP, Smith JD, Balasuriya BK, Mori SF, Hawk GS et al. Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model. Elife 2019;8. https:\/\/doi.org\/10.7554\/ELIFE.49920","DOI":"10.7554\/ELIFE.49920"},{"key":"5491_CR25","doi-asserted-by":"publisher","unstructured":"Schmitt RE, Dasgupta A, Arneson-Wissink PC, Datta S, Ducharme AM, Doles JD. Muscle stem cells contribute to long-term tissue repletion following surgical sepsis. J Cachexia Sarcopenia Muscle. 2023;14. https:\/\/doi.org\/10.1002\/jcsm.13214.","DOI":"10.1002\/jcsm.13214"},{"key":"5491_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-024-00982-w","volume":"30","author":"MS Kingren","year":"2024","unstructured":"Kingren MS, Keeble AR, Galvan-Lara AM, Ogle JM, Ungv\u00e1ri Z, St Clair DK, et al. Post-sepsis chronic muscle weakness can be prevented by Pharmacological protection of mitochondria. Mol Med. 2024;30:1\u201317. https:\/\/doi.org\/10.1186\/s10020-024-00982-w.","journal-title":"Mol Med"},{"key":"5491_CR27","doi-asserted-by":"publisher","unstructured":"Huang D, Li Y, Guo Y, Weng M, Ye H, Zhang Y, et al. Elevated levels of S100A8 and S100A9 exacerbate muscle mitochondrial fragmentation in sepsis-induced muscle atrophy. Commun Biol. 2025;8. https:\/\/doi.org\/10.1038\/S42003-025-07654-3.","DOI":"10.1038\/S42003-025-07654-3"},{"key":"5491_CR28","doi-asserted-by":"publisher","unstructured":"Leduc-Gaudet JP, Mayaki D, Reynaud O, Broering FE, Chaffer TJ, Hussain SNA et al. Parkin Overexpression Attenuates Sepsis-Induced Muscle Wasting. Cells 2020, Vol 9, Page 1454. 2020;9:1454. https:\/\/doi.org\/10.3390\/CELLS9061454","DOI":"10.3390\/CELLS9061454"},{"key":"5491_CR29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1177\/0148607116657649","volume":"41","author":"K Jiroutkov\u00e1","year":"2017","unstructured":"Jiroutkov\u00e1 K, Krajcov\u00e1 A, Ziak J, Fric M, Gojda J, Dzupa V, et al. Mitochondrial function in an in vitro model of skeletal muscle of patients with protracted critical illness and intensive care Unit-Acquired weakness. J Parenter Enter Nutr. 2017;41:1213\u201321. https:\/\/doi.org\/10.1177\/0148607116657649.","journal-title":"J Parenter Enter Nutr"},{"key":"5491_CR30","doi-asserted-by":"publisher","first-page":"9148246","DOI":"10.1155\/2022\/9148246","volume":"2022","author":"B Yang","year":"2022","unstructured":"Yang B, Yang X, Sun X, Shi J, Shen Y, Chen R. IL-6 deficiency attenuates skeletal muscle atrophy by inhibiting mitochondrial ROS production through the upregulation of PGC-1\u03b1 in septic mice. Oxid Med Cell Longev. 2022;2022:9148246. https:\/\/doi.org\/10.1155\/2022\/9148246.","journal-title":"Oxid Med Cell Longev"},{"key":"5491_CR31","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1172\/JCI130996","volume":"130","author":"D Patoli","year":"2020","unstructured":"Patoli D, Mignotte F, Deckert V, Dusuel A, Dumont A, Rieu A, et al. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis. J Clin Invest. 2020;130:5858\u201374. https:\/\/doi.org\/10.1172\/JCI130996.","journal-title":"J Clin Invest"},{"key":"5491_CR32","doi-asserted-by":"publisher","first-page":"6914849","DOI":"10.1155\/2019\/6914849","volume":"2019","author":"S Li","year":"2019","unstructured":"Li S, Hu Q, Huang J, Wu X, Ren J. Mitochondria-Derived Damage-Associated molecular patterns in sepsis: from bench to bedside. Oxid Med Cell Longev. 2019;2019:6914849. https:\/\/doi.org\/10.1155\/2019\/6914849.","journal-title":"Oxid Med Cell Longev"},{"key":"5491_CR33","doi-asserted-by":"publisher","unstructured":"Shi Y, Zhang H, Miao C. Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives. Cell Death Discovery. 2025 11:1 2025;11:1\u201312. https:\/\/doi.org\/10.1038\/s41420-025-02403-1","DOI":"10.1038\/s41420-025-02403-1"},{"key":"5491_CR34","doi-asserted-by":"publisher","first-page":"422344","DOI":"10.3389\/fimmu.2018.02685","volume":"9","author":"K Bomans","year":"2018","unstructured":"Bomans K, Schenz J, Sztwiertnia I, Schaack D, Weigand MA, Uhle F. Sepsis induces a long-lasting state of trained immunity in bone marrow monocytes. Front Immunol. 2018;9:422344. https:\/\/doi.org\/10.3389\/fimmu.2018.02685.","journal-title":"Front Immunol"},{"key":"5491_CR35","doi-asserted-by":"publisher","first-page":"L451","DOI":"10.1152\/AJPLUNG.00123.2021","volume":"321","author":"SJ Denstaedt","year":"2021","unstructured":"Denstaedt SJ, Bustamante AC, Newstead MW, Moore BB, Standiford TJ, Zemans RL, et al. Long-term survivors of murine sepsis are predisposed to enhanced LPS-induced lung injury and Proinflammatory immune reprogramming. Am J Physiol Lung Cell Mol Physiol. 2021;321:L451\u201365. https:\/\/doi.org\/10.1152\/AJPLUNG.00123.2021.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5491_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/SHK.0000000000001681","volume":"56","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yan C, Miao J, Pu K, Ma H, Wang Q. Muscle-Derived mitochondrial transplantation reduces inflammation, enhances bacterial clearance, and improves survival in Sepsis. Shock. 2021;56:108\u201318. https:\/\/doi.org\/10.1097\/SHK.0000000000001681.","journal-title":"Shock"},{"key":"5491_CR37","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.7150\/thno.81240","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Wang L, Wang B, Zhang Z, Jiang L, Qin Z, et al. NOX4 is a potential therapeutic target in septic acute kidney injury by inhibiting mitochondrial dysfunction and inflammation. Theranostics. 2023;13:2863\u201378. https:\/\/doi.org\/10.7150\/thno.81240.","journal-title":"Theranostics"},{"key":"5491_CR38","doi-asserted-by":"publisher","unstructured":"Ge Y, Huang M, Yao Y. ming. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis. Cytokine Growth Factor Rev 2019;45:24\u201334. https:\/\/doi.org\/10.1016\/J.CYTOGFR.2018.12.004","DOI":"10.1016\/J.CYTOGFR.2018.12.004"},{"key":"5491_CR39","doi-asserted-by":"publisher","unstructured":"Zhang H, Dong N, Yao Y. Optimal strategy for treatment of sepsis based on the host inflammatory reaction and immune response. J Intensive Med 2024;4. https:\/\/doi.org\/10.1016\/j.jointm.2023.10.002","DOI":"10.1016\/j.jointm.2023.10.002"},{"key":"5491_CR40","doi-asserted-by":"publisher","unstructured":"Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9. https:\/\/doi.org\/10.1186\/s40779-022-00422-y.","DOI":"10.1186\/s40779-022-00422-y"},{"key":"5491_CR41","doi-asserted-by":"publisher","unstructured":"Wang YC, Weng GP, Liu JP, Li L, Cheng QH. Elevated serum IL-37 concentrations in patients with sepsis. Medicine 2019;98. https:\/\/doi.org\/10.1097\/MD.0000000000014756","DOI":"10.1097\/MD.0000000000014756"},{"key":"5491_CR42","doi-asserted-by":"publisher","unstructured":"Chen Y, Guo DZ, Zhu CL, Ren SC, Sun CY, Wang Y, et al. The implication of targeting PD-1:PD-L1 pathway in treating sepsis through immunostimulatory and anti-inflammatory pathways. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1323797.","DOI":"10.3389\/fimmu.2023.1323797"},{"key":"5491_CR43","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3390\/MEDICINA60071174\/S1","volume":"60","author":"O Coman","year":"2024","unstructured":"Coman O, Grigorescu BL, Hu\u021banu A, Bac\u00e2rea A, V\u0103sie\u0219iu AM, Fodor R, \u0218tefania, et al. The role of programmed cell death 1\/programmed death ligand 1 (PD-1\/PD-L1) Axis in Sepsis-Induced apoptosis. Med (Lithuania). 2024;60:1174. https:\/\/doi.org\/10.3390\/MEDICINA60071174\/S1.","journal-title":"Med (Lithuania)"},{"key":"5491_CR44","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/medicina60071174","volume":"30","author":"S Huang","year":"2022","unstructured":"Huang S, Liu D, Sun J, Zhang H, Zhang J, Wang Q, et al. Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-\u03baB signaling pathway in CD4 T cells. Mol Ther. 2022;30:1227\u201338. https:\/\/doi.org\/10.3390\/medicina60071174.","journal-title":"Mol Ther"},{"key":"5491_CR45","doi-asserted-by":"publisher","first-page":"624272","DOI":"10.3389\/FIMMU.2020.624272","volume":"11","author":"MA McBride","year":"2021","unstructured":"McBride MA, Patil TK, Bohannon JK, Hernandez A, Sherwood ER, Patil NK. Immune checkpoints: novel therapeutic targets to attenuate Sepsis-Induced immunosuppression. Front Immunol. 2021;11:624272. https:\/\/doi.org\/10.3389\/FIMMU.2020.624272.","journal-title":"Front Immunol"},{"key":"5491_CR46","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/EJI.202049141","volume":"51","author":"M De Zuani","year":"2021","unstructured":"De Zuani M, Hortov\u00e1-Kohoutkov\u00e1 M, Andrej\u010dinov\u00e1 I, Tom\u00e1\u0161kov\u00e1 V, \u0160r\u00e1mek V, Hel\u00e1n M, et al. Human myeloid-derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data. Eur J Immunol. 2021;51:1785\u201391. https:\/\/doi.org\/10.1002\/EJI.202049141.","journal-title":"Eur J Immunol"},{"key":"5491_CR47","doi-asserted-by":"publisher","unstructured":"Yao RQ, Zhao PY, Li ZX, Liu YY, Zheng LY, Duan Y, et al. Single-cell transcriptome profiling of sepsis identifies HLA-DRlowS100Ahigh monocytes with immunosuppressive function. Mil Med Res. 2023;10. https:\/\/doi.org\/10.1186\/S40779-023-00462-Y.","DOI":"10.1186\/S40779-023-00462-Y"},{"key":"5491_CR48","doi-asserted-by":"publisher","first-page":"100817","DOI":"10.1016\/j.xcrm.2022.100817","volume":"3","author":"K Leventogiannis","year":"2022","unstructured":"Leventogiannis K, Kyriazopoulou E, Antonakos N, Kotsaki A, Tsangaris I, Markopoulou D, et al. Toward personalized immunotherapy in sepsis: the PROVIDE randomized clinical trial. Cell Rep Med. 2022;3:100817. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100817.","journal-title":"Cell Rep Med"},{"key":"5491_CR49","doi-asserted-by":"publisher","unstructured":"Helfinger V, Palfi K, Weigert A, Schr\u00f6der K. The NADPH oxidase Nox4 controls macrophage polarization in an NF\u03baB dependent manner. Oxid Med Cell Longev. 2019;2019. https:\/\/doi.org\/10.1155\/2019\/3264858.","DOI":"10.1155\/2019\/3264858"},{"key":"5491_CR50","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/BIOLOGY12060776","volume":"12","author":"D Iacobazzi","year":"2023","unstructured":"Iacobazzi D, Convertini P, Todisco S, Santarsiero A, Iacobazzi V, Infantino V. New insights into NF-\u03baB signaling in innate immunity: focus on immunometabolic crosstalks. Biology (Basel). 2023;12:776. https:\/\/doi.org\/10.3390\/BIOLOGY12060776.","journal-title":"Biology (Basel)"},{"key":"5491_CR51","doi-asserted-by":"publisher","unstructured":"Yu X, Hu X, Wang D, Cui P, Zeng M, Li M et al. Macrophage S1PR2 drives Sepsis-induced immunosuppression by exacerbating mitochondrial fragmentation. Https:\/\/DoiOrg\/101165\/Rcmb2024-0161OC 2024. https:\/\/doi.org\/10.1165\/RCMB.2024-0161OC","DOI":"10.1165\/RCMB.2024-0161OC"},{"key":"5491_CR52","doi-asserted-by":"publisher","unstructured":"Sahoo DK, Wong D, Patani A, Paital B, Yadav VK, Patel A, et al. Exploring the role of antioxidants in sepsis-associated oxidative stress: a comprehensive review. Front Cell Infect Microbiol. 2024;14. https:\/\/doi.org\/10.3389\/fcimb.2024.1348713.","DOI":"10.3389\/fcimb.2024.1348713"},{"key":"5491_CR53","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/S41590-020-0673-X","volume":"21","author":"A Roquilly","year":"2020","unstructured":"Roquilly A, Jacqueline C, Davieau M, Moll\u00e9 A, Sadek A, Fourgeux C, et al. Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysis. Nat Immunol. 2020;21:636\u201348. https:\/\/doi.org\/10.1038\/S41590-020-0673-X.","journal-title":"Nat Immunol"},{"key":"5491_CR54","doi-asserted-by":"publisher","unstructured":"Hu D, Sheeja Prabhakaran H, Zhang YY, Luo G, He W, Liou YC. Mitochondrial dysfunction in sepsis: mechanisms and therapeutic perspectives. Critical Care. 2024 28:1 2024;28:1\u201319. https:\/\/doi.org\/10.1186\/S13054-024-05069-W","DOI":"10.1186\/S13054-024-05069-W"},{"key":"5491_CR55","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1161\/ATVBAHA.119.312754","volume":"39","author":"FM Davis","year":"2019","unstructured":"Davis FM, Schaller MA, Dendekker A, Joshi AD, Kimball AS, Evanoff H, et al. Sepsis induces prolonged epigenetic modifications in bone marrow and peripheral macrophages impairing inflammation and wound healing. Arterioscler Thromb Vasc Biol. 2019;39:2353\u201366. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312754.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5491_CR56","doi-asserted-by":"publisher","unstructured":"Sari MI, Ilyas S. The expression levels and concentrations of PD-1 and PD-L1 proteins in septic patients: A systematic review. Diagnostics. 2022;12. https:\/\/doi.org\/10.3390\/diagnostics12082004.","DOI":"10.3390\/diagnostics12082004"},{"key":"5491_CR57","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1139\/APNM-2020-0005","volume":"45","author":"JF Halling","year":"2020","unstructured":"Halling JF, Pilegaard H. PGC-1\u03b1-mediated regulation of mitochondrial function and physiological implications. Appl Physiol Nutr Metab. 2020;45:927\u201336. https:\/\/doi.org\/10.1139\/APNM-2020-0005.","journal-title":"Appl Physiol Nutr Metab"},{"key":"5491_CR58","doi-asserted-by":"publisher","unstructured":"Nakamori Y, Park EJ, Shimaoka M. Immune deregulation in Sepsis and septic shock: reversing immune paralysis by targeting PD-1\/PD-L1 pathway. Front Immunol. 2021;11. https:\/\/doi.org\/10.3389\/FIMMU.2020.624279.","DOI":"10.3389\/FIMMU.2020.624279"},{"key":"5491_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/J.FREERADBIOMED.2018.05.073","volume":"123","author":"G Hong","year":"2018","unstructured":"Hong G, Zheng D, Zhang L, Ni R, Wang G, Fan GC, et al. Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis. Free Radic Biol Med. 2018;123:125\u201337. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2018.05.073.","journal-title":"Free Radic Biol Med"},{"key":"5491_CR60","doi-asserted-by":"publisher","unstructured":"Ye W, Liu X, Bai Y, Tang N, Wu G, Wang X, et al. Sepsis activates the tlr4\/myd88 pathway in Schwann cells to promote infiltration of macrophages, thereby impeding neuromuscular function. Shock. 2021;55. https:\/\/doi.org\/10.1097\/SHK.0000000000001557.","DOI":"10.1097\/SHK.0000000000001557"},{"key":"5491_CR61","doi-asserted-by":"publisher","unstructured":"Sasegbon A, O\u2019Shea L, Hamdy S. Examining the relationship between sepsis and oropharyngeal dysphagia in hospitalised elderly patients: A retrospective cohort study. Frontline Gastroenterol. 2018;9. https:\/\/doi.org\/10.1136\/flgastro-2018-100994.","DOI":"10.1136\/flgastro-2018-100994"},{"key":"5491_CR62","doi-asserted-by":"publisher","unstructured":"Hongo T, Yumoto T, Naito H, Fujiwara T, Kondo J, Nozaki S, et al. Frequency, associated factors, and associated outcomes of dysphagia following sepsis. Australian Crit Care. 2023;36. https:\/\/doi.org\/10.1016\/j.aucc.2022.06.003.","DOI":"10.1016\/j.aucc.2022.06.003"},{"key":"5491_CR63","doi-asserted-by":"publisher","unstructured":"van der Slikke EC, An AY, Hancock REW, Bouma HR. Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities. EBioMedicine 2020;61. https:\/\/doi.org\/10.1016\/J.EBIOM.2020.103044","DOI":"10.1016\/J.EBIOM.2020.103044"},{"key":"5491_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/SHK.0000000000001843","volume":"57","author":"RT Mankowski","year":"2022","unstructured":"Mankowski RT, Laitano O, Darden D, Kelly L, Munley J, Loftus TJ, et al. Sepsis-Induced myopathy and gut Microbiome dysbiosis: mechanistic links and therapeutic targets. Shock. 2022;57:15\u201323. https:\/\/doi.org\/10.1097\/SHK.0000000000001843.","journal-title":"Shock"},{"key":"5491_CR65","unstructured":"Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. MTOR- and HIF-1\u03b1-mediated aerobic Glycolysis as metabolic basis for trained immunity. Science. 1979;2014345. https:\/\/www.science.org\/doi\/10.1126\/science.1250684."},{"key":"5491_CR66","doi-asserted-by":"publisher","unstructured":"Jiang J, Huang K, Xu S, Garcia JGN, Wang C, Cai H. Targeting NOX4 alleviates sepsis-induced acute lung injury via Attenuation of redox-sensitive activation of CaMKII\/ERK1\/2\/MLCK and endothelial cell barrier dysfunction. Redox Biol. 2020;36. https:\/\/doi.org\/10.1016\/j.redox.2020.101638.","DOI":"10.1016\/j.redox.2020.101638"},{"key":"5491_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/J.MEDJ.2024.12.003","author":"XF Sun","year":"2025","unstructured":"Sun XF, Luo WC, Huang SQ, Zheng YJ, Xiao L, Zhang ZW, et al. Immune-cell signatures of persistent inflammation, immunosuppression, and catabolism syndrome after sepsis. Med (N Y). 2025. https:\/\/doi.org\/10.1016\/J.MEDJ.2024.12.003.","journal-title":"Med (N Y)"},{"key":"5491_CR68","doi-asserted-by":"publisher","unstructured":"Valsamaki A, Vazgiourakis V, Mantzarlis K, Stamatiou R, Makris D. MicroRNAs in Sepsis. Biomedicines. 2024;12(2049). https:\/\/doi.org\/10.3390\/biomedicines12092049.","DOI":"10.3390\/biomedicines12092049"},{"key":"5491_CR69","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1615\/CRITREVIMMUNOL.2023051651","volume":"44","author":"P Wan","year":"2024","unstructured":"Wan P, Tan X, Sheng M, Xiang Y, Wang P, Yu M. Platelet Exosome-Derived miR-223-3p regulates pyroptosis in the cell model of Sepsis-Induced acute renal injury by targeting mediates NLRP3. Crit Reviews\u2122 Immunol. 2024;44:53\u201365. https:\/\/doi.org\/10.1615\/CRITREVIMMUNOL.2023051651.","journal-title":"Crit Reviews\u2122 Immunol"},{"key":"5491_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41598-020-74965-2","volume":"10","author":"D Liu","year":"2020","unstructured":"Liu D, Wang Z, Wang H, Ren F, Li Y, Zou S, et al. The protective role of miR-223 in sepsis-induced mortality. Sci Rep. 2020;10:1\u201310. https:\/\/doi.org\/10.1038\/S41598-020-74965-2.","journal-title":"Sci Rep"},{"key":"5491_CR71","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/JLB.4MR0922-690RR","volume":"112","author":"JC Rincon","year":"2022","unstructured":"Rincon JC, Efron PA, Moldawer LL. Immunopathology of chronic critical illness in sepsis survivors: role of abnormal myelopoiesis. J Leukoc Biol. 2022;112:1525\u201334. https:\/\/doi.org\/10.1002\/JLB.4MR0922-690RR.","journal-title":"J Leukoc Biol"},{"key":"5491_CR72","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/1744666X.2021.1875820","volume":"17","author":"E C\u00f3rneo","year":"2021","unstructured":"C\u00f3rneo E, da Michels S, Dal-Pizzol M. Sepsis, immunosuppression and the role of epigenetic mechanisms. Expert Rev Clin Immunol. 2021;17:169\u201376. https:\/\/doi.org\/10.1080\/1744666X.2021.1875820.","journal-title":"Expert Rev Clin Immunol"},{"key":"5491_CR73","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(16)30119-4","volume":"2","author":"BW Haak","year":"2017","unstructured":"Haak BW, Wiersinga WJ. The role of the gut microbiota in sepsis. Lancet Gastroenterol Hepatol. 2017;2:135\u201343. https:\/\/doi.org\/10.1016\/S2468-1253(16)30119-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"5491_CR74","doi-asserted-by":"publisher","first-page":"S264","DOI":"10.1093\/INFDIS\/JIAA682","volume":"223","author":"WD Miller","year":"2021","unstructured":"Miller WD, Keskey R, Alverdy JC. Sepsis and the microbiome: A vicious cycle. J Infect Dis. 2021;223:S264\u20139. https:\/\/doi.org\/10.1093\/INFDIS\/JIAA682.","journal-title":"J Infect Dis"},{"key":"5491_CR75","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1164\/RCCM.201211-1983OC","volume":"187","author":"O Takasu","year":"2013","unstructured":"Takasu O, Gaut JP, Watanabe E, To K, Fagley RE, Sato B, et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med. 2013;187:509\u201317. https:\/\/doi.org\/10.1164\/RCCM.201211-1983OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"5491_CR76","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/STEM.3375","volume":"39","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Yuan L, Li L, Liu F, Liu J, Chen Y, et al. Mitochondrial transfer from mesenchymal stem cells to macrophages restricts inflammation and alleviates kidney injury in diabetic nephropathy mice via PGC-1\u03b1 activation. Stem Cells. 2021;39:913\u201328. https:\/\/doi.org\/10.1002\/STEM.3375.","journal-title":"Stem Cells"},{"key":"5491_CR77","doi-asserted-by":"publisher","unstructured":"Kong S, Cai B, Nie Q. PGC-1\u03b1 affects skeletal muscle and adipose tissue development by regulating mitochondrial biogenesis. Molecular Genetics and Genomics. 2022 297:3 2022;297:621\u201333. https:\/\/doi.org\/10.1007\/S00438-022-01878-2","DOI":"10.1007\/S00438-022-01878-2"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05491-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-025-05491-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-025-05491-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:42:46Z","timestamp":1759405366000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-025-05491-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5491"],"URL":"https:\/\/doi.org\/10.1186\/s13054-025-05491-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"418"}}